Cargando…
Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy
A major drawback of radiotherapy is the accelerated growth of the surviving tumor cells. Radiotherapy generates a variety of lipids that bind to the receptor for platelet-activating factor, expressed by cells in the tumor microenvironment. In the present study, using the TC-1 tumor cell line, we fou...
Autores principales: | da Silva-Jr, I A, Chammas, R, Lepique, A P, Jancar, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294253/ https://www.ncbi.nlm.nih.gov/pubmed/28134937 http://dx.doi.org/10.1038/oncsis.2016.90 |
Ejemplares similares
-
Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017) -
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
por: de Oliveira, Soraya I, et al.
Publicado: (2010) -
Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2018) -
Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death
por: da Silva-Junior, Ildefonso Alves, et al.
Publicado: (2018) -
Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients
por: Harishkumar, Rajendran, et al.
Publicado: (2022)